Inventaire - your friends and communities are your best library

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial

লেখক

Nicola A Hanania

Theodore C. Lystig

এতে প্রকাশিত: Respiratory Research

তারিখে প্রকাশিত: 2011-01-11

মূল বিষয়: রোগী, দীর্ঘস্থায়ী অবরোধক ফুসফুসীয় ব্যাধি

Cites articles 24

তারিখ

শিরোনাম

লেখকগণ

2008-10-05

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

Marc Decramer, Matthew J. Peters
2008-02-01

Outcomes for COPD pharmacological trials: from lung function to biomarkers

William MacNee, Marc Miravitlles, Clive Page, American Thoracic Society
2008-02-06

Bronchodilator responsiveness in patients with COPD.
2008-05-01

Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility.

Glenn Crater, Eugene R Bleecker
2007-09-15

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Chris van Weel, Antonio Anzueto
2006-02-23

Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials

Frank Sciurba, Robert A. Wise
2005-07-01

Bronchodilator response in the lung health study over 11 yrs.
2004-08-01

Therapeutic responses in asthma and COPD. Bronchodilators
2004-01-01

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial
2003-08-01

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

Sally Spencer
2003-05-01

Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses,Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses
2003-11-01

Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes,Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *
1999-04-01

Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease
1999-04-01

Efficacy of salmeterol xinafoate in the treatment of COPD
1998-11-01

Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease
1995-09

Standardization of Spirometry, 1994 Update. American Thoracic Society
1993-11-01

Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation
1992-06-01

Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group

Hubertus Adrianus Marie Kerstjens
1992-06-01

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

Frances Quirk
1986-05-01

Bronchodilator response in chronic obstructive pulmonary disease
1985-10-01

The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables.
1983-07-01

Bronchodilator testing: confidence intervals derived from placebo inhalations
1981-07-01

Changes in measured spirometric indices. What is significant?
1974-05-01

Criteria for the assessment of reversibility in airways obstruction. Report of the Committee on Emphysema American College of Chest Physicians

নিবন্ধ - wd:Q34521884

জায়ে আপনাকে স্বাগত

the library of your friends and communities

আরো জানুন